Screening for ALK Rearrangements in Lung Cancer: Time for a New Generation of Diagnostics?

por Dagogo-Jack, Ibiayi, Shaw, Alice T.
Publicado 2016

The role of plasma genotyping in ALK- and ROS1-rearranged lung cancer

por Dagogo-Jack, Ibiayi, Ritterhouse, Lauren L.
Publicado 2020

Extrathoracic Metastases in Pleural Mesothelioma

por Dagogo-Jack, Ibiayi, Yeap, Beow Y., Mino-Kenudson, Mari, Digumarthy, Subba R.
Publicado 2023

Radiomic features of primary tumor by lung cancer stage: analysis in BRAF mutated non-small cell lung cancer

por Padole, Atul, Singh, Ramandeep, Zhang, Eric W., Mendoza, Dexter P., Dagogo-Jack, Ibiayi, Kalra, Mannudeep K., Digumarthy, Subba R.
Publicado 2020

Management of Lung Cancer in the Patient with Interstitial Lung Disease

por Frank, Angela J, Dagogo-Jack, Ibiayi, Dobre, Ioana A, Tait, Sarah, Schumacher, Lana, Fintelmann, Florian J, Fingerman, Leah M, Keane, Florence K, Montesi, Sydney B
Publicado 2022

Clinicopathologic Characteristics and Outcomes for Patients With KRAS G12D-Mutant NSCLC

por Cooper, Alissa J., Muzikansky, Alona, Lennerz, Jochen, Narinesingh, Farhaana, Mino-Kenudson, Mari, Hung, Yin P., Piotrowska, Zofia, Dagogo-Jack, Ibiayi, Sequist, Lecia V., Gainor, Justin F., Lin, Jessica J., Heist, Rebecca S.
Publicado 2022

Efficacy and Tolerability of ALK/MET Combinations in Patients With ALK-Rearranged Lung Cancer With Acquired MET Amplification: A Retrospective Analysis

por Dagogo-Jack, Ibiayi, Kiedrowski, Lesli A., Heist, Rebecca S., Lin, Jessica J., Meador, Catherine B., Krueger, Elizabeth A., Do, Andrew, Peterson, Jennifer, Sequist, Lecia V., Gainor, Justin F., Lennerz, Jochen K., Digumarthy, Subba R.
Publicado 2023

Emergence of FGFR3-TACC3 fusions as a potential by-pass resistance mechanism to EGFR tyrosine kinase inhibitors in EGFR mutated NSCLC patients

por Ou, Sai-Hong Ignatius, Horn, Leora, Cruz, Marcelo, Vafai, Davood, Lovly, Christine M., Spradlin, Allison, Williamson, Michael J., Dagogo-Jack, Ibiayi, Johnson, Adrienne, Miller, Vincent A., Gadgeel, Shirish, Ali, Siraj M., Schrock, Alexa B.
Publicado 2017

B-Cell Infiltrate in the Tumor Microenvironment Is Associated With Improved Survival in Resected Lung Adenocarcinoma

por Dagogo-Jack, Ibiayi, Valiev, Ivan, Kotlov, Nikita, Belozerova, Anna, Lopareva, Aleksandra, Butusova, Anna, Samarina, Naira, Boyko, Alexandra, Xiang, Zhongmin, Johnson, Monique, Degryse, Sandrine, Keane, Florence K., Sequist, Lecia V., Lanuti, Michael, Fowler, Nathan, Mino-Kenudson, Mari, Bagaev, Alexander
Publicado 2023

Small cell transformation of ROS1 fusion-positive lung cancer resistant to ROS1 inhibition

por Lin, Jessica J., Langenbucher, Adam, Gupta, Pranav, Yoda, Satoshi, Fetter, Isobel J., Rooney, Marguerite, Do, Andrew, Kem, Marina, Chang, Kylie Prutisto, Oh, Audris Y., Chin, Emily, Juric, Dejan, Corcoran, Ryan B., Dagogo-Jack, Ibiayi, Gainor, Justin F., Stone, James R., Lennerz, Jochen K., Lawrence, Michael S., Hata, Aaron N., Mino-Kenudson, Mari, Shaw, Alice T.
Publicado 2020

Coronavirus Disease 2019 Infection in a Patient Population with Lung Cancer: Incidence, Presentation, and Alternative Diagnostic Considerations

por Piper-Vallillo, Andrew J., Mooradian, Meghan J., Meador, Catherine B., Yeap, Beow Y., Peterson, Jennifer, Sakhi, Mustafa, Do, Andrew, Zubiri, Leyre, Stevens, Sara, Vaughn, Jeanne, Goodwin, Kelly, Gavralidis, Alexander, Willers, Henning, Miller, Adam, Farago, Anna, Piotrowska, Zofia, Lin, Jessica J., Dagogo-Jack, Ibiayi, Lennes, Inga T., Sequist, Lecia V., Temel, Jennifer S., Heist, Rebecca S., Digumarthy, Subba, Reynolds, Kerry L., Gainor, Justin F.
Publicado 2020

Clinical Utility of Rapid EGFR Genotyping in Advanced Lung Cancer

por Dagogo-Jack, Ibiayi, Azzolli, Christopher G., Fintelmann, Florian, Mino-Kenudson, Mari, Farago, Anna F., Gainor, Justin F., Jiang, Ginger, Piotrowska, Zofia, Heist, Rebecca S., Lennes, Inga T., Temel, Jennifer S., Mooradian, Meghan J., Lin, Jessica J., Digumarthy, Subba R., Batten, Julie M., Robinson, Hayley, Nose, Vania, Rivera, Miguel, Nardi, Valentina, Dias-Santagata, Dora, Le, Long P., Sequist, Lecia V., Pitman, Martha, Shepard, Jo-Anne O., Shaw, Alice T., Iafrate, A. John, Lennerz, Jochen K.
Publicado 2018

Clinical Activity of Mitogen-Activated Protein Kinase–Targeted Therapies in Patients With Non–V600 BRAF-Mutant Tumors

por Dankner, Matthew, Wang, Yifan, Fazelzad, Rouhi, Johnson, Benny, Nebhan, Caroline A., Dagogo-Jack, Ibiayi, Myall, Nathaniel J., Richtig, Georg, Bracht, Jillian W.P., Gerlinger, Marco, Shinozaki, Eiji, Yoshino, Takayuki, Kotani, Daisuke, Fangusaro, Jason R., Gautschi, Oliver, Mazieres, Julien, Sosman, Jeffrey A., Kopetz, Scott, Subbiah, Vivek, Davies, Michael A., Groover, Anna L., Sullivan, Ryan J., Flaherty, Keith T., Johnson, Douglas B., Benedetti, Andrea, Cescon, David W., Spreafico, Anna, Zogopoulos, George, Rose, April A.N.
Publicado 2022

Phase II study of ipilimumab and nivolumab in leptomeningeal carcinomatosis

por Brastianos, Priscilla K., Strickland, Matthew R., Lee, Eudocia Quant, Wang, Nancy, Cohen, Justine V., Chukwueke, Ugonma, Forst, Deborah Anne, Eichler, April, Overmoyer, Beth, Lin, Nancy U., Chen, Wendy Y., Bardia, Aditya, Juric, Dejan, Dagogo-Jack, Ibiayi, White, Michael D., Dietrich, Jorg, Nayyar, Naema, Kim, Albert E., Alvarez-Breckenridge, Christopher, Mahar, Maura, Mora, Joana L., Nahed, Brian V., Jones, Pamela S., Shih, Helen A., Gerstner, Elizabeth R., Giobbie-Hurder, Anita, Carter, Scott L., Oh, Kevin, Cahill, Daniel P., Sullivan, Ryan J.
Publicado 2021

B cell‐dependent subtypes and treatment‐based immune correlates to survival in stage 3 and 4 lung adenocarcinomas

por Raju Paul, Susan, Valiev, Ivan, Korek, Skylar E., Zyrin, Vladimir, Shamsutdinova, Diana, Gancharova, Olga, Zaitsev, Alexander, Nuzhdina, Ekaterina, Davies, Diane L., Dagogo‐Jack, Ibiayi, Frenkel, Felix, Brown, Jessica H., Hess, Joshua M., Viet, Sarah, Petersen, Jason L., Wright, Cameron D., Ott, Harald C., Auchincloss, Hugh G., Muniappan, Ashok, Shioda, Toshihiro, Lanuti, Michael, Davis, Christel M., Ehli, Erik A., Hung, Yin P., Mino‐Kenudson, Mari, Tsiper, Maria, Sluder, Ann E., Reeves, Patrick M., Kotlov, Nikita, Bagaev, Alexander, Ataullakhanov, Ravshan, Poznansky, Mark C.
Publicado 2023

Genomic characterization of human brain metastases identifies drivers of metastatic lung adenocarcinoma

por Shih, David J. H., Nayyar, Naema, Bihun, Ivanna, Dagogo-Jack, Ibiayi, Gill, Corey M., Aquilanti, Elisa, Bertalan, Mia, Kaplan, Alexander, D’Andrea, Megan R., Chukwueke, Ugonma, Ippen, Franziska Maria, Alvarez-Breckenridge, Christopher, Camarda, Nicholas D., Lastrapes, Matthew, McCabe, Devin, Kuter, Ben, Kaufman, Benjamin, Strickland, Matthew R., Martinez-Gutierrez, Juan Carlos, Nagabhushan, Deepika, De Sauvage, Magali, White, Michael D., Castro, Brandyn A., Hoang, Kaitlin, Kaneb, Andrew, Batchelor, Emily D., Paek, Sun Ha, Park, Sun Hye, Martinez-Lage, Maria, Berghoff, Anna S., Merrill, Parker, Gerstner, Elizabeth R., Batchelor, Tracy T., Frosch, Matthew P., Frazier, Ryan P., Borger, Darrell R., Iafrate, A. John, Johnson, Bruce E., Santagata, Sandro, Preusser, Matthias, Cahill, Daniel P., Carter, Scott L., Brastianos, Priscilla K.
Publicado 2020

Implementation and Clinical Adoption of Precision Oncology Workflows Across a Healthcare Network

por Dias-Santagata, Dora, Heist, Rebecca S, Bard, Adam Z, da Silva, Annacarolina F L, Dagogo-Jack, Ibiayi, Nardi, Valentina, Ritterhouse, Lauren L, Spring, Laura M, Jessop, Nicholas, Farahani, Alexander A, Mino-Kenudson, Mari, Allen, Jill, Goyal, Lipika, Parikh, Aparna, Misdraji, Joseph, Shankar, Ganesh, Jordan, Justin T, Martinez-Lage, Maria, Frosch, Matthew, Graubert, Timothy, Fathi, Amir T, Hobbs, Gabriela S, Hasserjian, Robert P, Raje, Noopur, Abramson, Jeremy, Schwartz, Joel H, Sullivan, Ryan J, Miller, David, Hoang, Mai P, Isakoff, Steven, Ly, Amy, Bouberhan, Sara, Watkins, Jaclyn, Oliva, Esther, Wirth, Lori, Sadow, Peter M, Faquin, William, Cote, Gregory M, Hung, Yin P, Gao, Xin, Wu, Chin-Lee, Garg, Salil, Rivera, Miguel, Le, Long P, John Iafrate, A, Juric, Dejan, Hochberg, Ephraim P, Clark, Jeffrey, Bardia, Aditya, Lennerz, Jochen K
Publicado 2022